EHA COVID-19 Webinar Series: Session 01 (COVID-19 & Hematology Patient Care)
From Reagan Sanders
Featuring an expert panel from Italy, Spain and Germany, EHA together with EBMT address urgent questions relating to cancer #patientcare during the #coronavirus crisis, in this first webinar session.
What are the current treatments for patients with hematological disease and COVID-19? Has there been a particular increase in the incidents of COVID-19 infections in patients who underwent an intensive chemotherapy program? What advise can they share with regards to preventing COVID-19 from spreading to health care staff, and what recommendations do they have on how to be well-prepared in your respective centers?
Tune in and learn from the 4 experts, who will be sharing their experiences in treating hematology patients undergoing intensive treatment, in this current crisis.
• Prof Alessandro Rambaldi (U.O. Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy)
• Prof Jose M Ribera (Josep Carreras Leukemia Research Institute, Barcelona, Spain)
• Prof Dr Marie von Lilienfeld-Toal (Universitätsklinikum Jena, Germany)
• Prof Malgorzata Mikulska (University of Genova, Italy)
This is a first, in a series of webinars looking at the care of hematology patients during the COVID-19 crisis. Visit https://ehaweb.org/covid-19/webinars/, for more information on our upcoming webinars (details coming soon).